Department of Esophagogastric Surgery, Oxford Cancer and Hematology Centre, Churchill Hospital, Oxford, UK.
Dis Esophagus. 2011 Apr;24(3):138-44. doi: 10.1111/j.1442-2050.2010.01107.x. Epub 2010 Sep 2.
The left thoracoabdominal approach to esophagectomy is not widely performed, despite offering excellent exposure to tumors of the esophagogastric junction. Criticisms of the approach have focused on historically high rates of mortality, complications, and positive resection margins. Our aim was to determine whether left thoracoabdominal esophagectomy could combine a radical oncological resection with acceptably low mortality and morbidity. A retrospective cohort study of all left thoracoabdominal esophagectomies was performed at a single specialist center over an 11-year period. Primary outcomes were in-hospital mortality, complications, resection margin involvement, and lymph node yield; secondary outcomes were 1-year and 5-year survival. Two hundred eleven esophagectomies were performed. In-hospital mortality was 5.7% (12/211). One hundred one subjects (47.9%) had an uncomplicated recovery; 110 subjects (52.1%) developed at least one complication. There were 15 clinically significant anastomotic leaks (7.1%). Twenty-four subjects (11.4%) required emergency reoperation, the most common indication being anastomotic leakage. Complete tumor excision (R0 resection) was achieved in 151 of 211 cases (71.6%); median lymph node yield was 24. One-year and 5-year survival rates were 70% (147/211) and 21% (24/116), respectively. Left thoracoabdominal esophagectomy can combine a radical oncological resection with acceptably low mortality and morbidity.
左开胸经胸腹联合食管切除术并不广泛开展,尽管它为胃食管结合部肿瘤提供了极好的显露。该术式的批评集中在历史上较高的死亡率、并发症发生率和阳性切缘率。我们的目的是确定左开胸经胸腹联合食管切除术是否可以将根治性肿瘤切除术与可接受的低死亡率和低发病率相结合。对一家专业中心在 11 年期间进行的所有左开胸经胸腹联合食管切除术进行了回顾性队列研究。主要结局是院内死亡率、并发症、切缘受累和淋巴结产量;次要结局是 1 年和 5 年生存率。共进行了 211 例食管切除术。院内死亡率为 5.7%(12/211)。101 例(47.9%)患者恢复顺利;110 例(52.1%)发生至少一种并发症。有 15 例临床显著吻合口漏(7.1%)。24 例(11.4%)需要紧急再次手术,最常见的指征是吻合口漏。211 例中有 151 例(71.6%)完全切除肿瘤(R0 切除);中位淋巴结产量为 24 个。1 年和 5 年生存率分别为 70%(147/211)和 21%(24/116)。左开胸经胸腹联合食管切除术可以将根治性肿瘤切除术与可接受的低死亡率和低发病率相结合。